Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2511]

Signature of an ineffective immune response to cancer revealed

Signature of an ineffective immune response to cancer revealed

New finding: Biomarker indicates tumour aggressiveness and poor prognosis in men with prostate cancer

New finding: Biomarker indicates tumour aggressiveness and poor prognosis in men with prostate cancer

Body fat distribution linked to higher risk of aggressive prostate cancer

Body fat distribution linked to higher risk of aggressive prostate cancer

Body fat distribution linked to higher risk of aggressive prostate cancer

Body fat distribution linked to higher risk of aggressive prostate cancer

ASCO 2019: Men who choose active surveillance for early prostate cancer often don't follow monitoring rules

ASCO 2019: Men who choose active surveillance for early prostate cancer often don't follow monitoring rules

ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery

ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery

UT Southwestern develops test to predict immunotherapy response in kidney cancer

UT Southwestern develops test to predict immunotherapy response in kidney cancer

ASCO 2019: No benefit from pazopanib in advanced kidney cancer after surgery to remove metastases

ASCO 2019: No benefit from pazopanib in advanced kidney cancer after surgery to remove metastases

ASCO 2019: International clinical trial of new drug for men with advanced prostate cancer yields strong result

ASCO 2019: International clinical trial of new drug for men with advanced prostate cancer yields strong result

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced...

More from ecancer